SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-193236
Filing Date
2019-07-12
Accepted
2019-07-12 16:31:03
Documents
1
Group Members
SOFTBANK VISION FUND L.P.SVF GP (JERSEY) LTDSVF HOLDINGS (UK) LLP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d762381dsc13da.htm SC 13D/A 79773
  Complete submission text file 0001193125-19-193236.txt   81384
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (441) 295-5950
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-89732 | Film No.: 19953297
SIC: 2834 Pharmaceutical Preparations

Mailing Address 69 GROSVENOR STREET LONDON X0 W1K3JP
Business Address 69 GROSVENOR STREET LONDON X0 W1K3JP 6508435214
SVF Investments (UK) Ltd (Filed by) CIK: 0001716729 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A